Here are 1-2 brief analogies for AdaptHealth:

• Amazon for home medical equipment and supplies.

• Chewy for chronic medical supplies.

• Sleep Therapy Equipment & Services: Provides CPAP and bi-PAP equipment, supplies, and related services for individuals with obstructive sleep apnea.
• Diabetes Management Devices & Supplies: Offers medical devices and supplies, including continuous glucose monitors and insulin pumps, for the treatment of diabetes.
• Home Oxygen & Chronic Therapy Services: Delivers oxygen and related chronic therapy services directly to patients' homes.
• General Home Medical Equipment (HME): Supplies a range of home medical equipment to patients transitioning from acute care and other facilities.
• Specialized Medical Supplies: Provides supplies for chronically ill patients with needs such as wound care, urological, incontinence, ostomy, and nutritional support.

AdaptHealth Corp. (AHCO) primarily sells its home medical equipment, supplies, and related services directly to individuals, also referred to as patients or beneficiaries. Based on the services described, its major customer categories include:

• Individuals with Obstructive Sleep Apnea: Patients who require sleep therapy equipment, such as CPAP and bi-PAP devices, and related supplies and services.
• Patients with Diabetes: Individuals needing medical devices and supplies for diabetes management, including continuous glucose monitors and insulin pumps.
• Chronically Ill Patients with Various Home Medical Equipment Needs: This broad category includes patients requiring oxygen therapy, wound care supplies, urological supplies, incontinence products, ostomy supplies, nutritional support, and general home medical equipment following discharge from acute care facilities.

Suzanne Foster
Chief Executive Officer

Suzanne Foster has been the Chief Executive Officer of AdaptHealth Corp. since May 2024. She brings over 25 years of experience in the healthcare industry, serving as a global leader. Prior to AdaptHealth, Ms. Foster was President of Beckman Coulter Life Sciences for Danaher Corporation from April 2022 to May 2024. Her previous roles include President of At Home Solutions for Cardinal Health (January 2020 to April 2022), President of Stanley Healthcare (April 2018 to January 2020), and general manager of Medtronic Advanced Energy (August 2011 to March 2018). She also served as Vice President of Global Business Operations at Salient Surgical Technologies, which was later acquired by Medtronic. Ms. Foster holds a Master of Public Health from Harvard T.H. Chan School of Public Health and a Juris Doctor from Suffolk University Law School.

Jason Clemens
Chief Financial Officer

Jason Clemens was appointed Chief Financial Officer of AdaptHealth, effective August 3, 2020. He joined AdaptHealth from MEDNAX, Inc., where he served as Senior Vice President and Operations Chief Financial Officer, holding positions of increasing responsibility in operations management and finance over a nine-year career. Before MEDNAX, Mr. Clemens gained experience with the United States Army, supporting the Republic of Korea Army, and later held roles in operations management and finance at Accenture, Lennar, and Ryder. He holds a bachelor's degree in Accounting from LaSalle University, a B.S. in industrial engineering from Lehigh, an M.S. in finance, and an MBA from Indiana University Kelley School of Business. Mr. Clemens is also a Chartered Financial Analyst (CFA) and a Certified Six Sigma Blackbelt.

Scott Barnhart
Chief Operating Officer

Scott Barnhart was appointed Chief Operating Officer of AdaptHealth, effective September 23, 2024. He brings over 30 years of leadership experience in global operations, including supply chain management, manufacturing, procurement, logistics, customer service, and product portfolio management. Most recently, he served as Chief Operating Officer of Qurate Retail Group. Prior to that, Mr. Barnhart held senior executive positions at several companies across various industries, including his role as President of Global Medical Products & Supply Chain at Cardinal Health.

Russell Schuster
Chief Commercial Officer

Russell Schuster is the Chief Commercial Officer at AdaptHealth. He previously served as Senior Vice President, leading Global Strategy and Business Development efforts for the Medical Segment at Cardinal Health. Mr. Schuster joined Cardinal Health in 2017 as a Vice President, Corporate Development, where he was responsible for identifying and executing M&A, Partnerships, and Joint Ventures across the enterprise. He has nearly 25 years of experience in corporate finance, strategy, and M&A work, and prior to Cardinal Health, he led corporate development efforts for Republic Services.

Albert Prast
Chief Technology & Innovation Officer

Albert Prast serves as AdaptHealth's Chief Technology & Innovation Officer.

The key risks to AdaptHealth's business, which provides home medical equipment and related services, include significant exposure to reimbursement and regulatory changes, high debt levels with sensitivity to interest rates, and vulnerabilities within its supply chain coupled with inflationary and labor pressures.

1. Reimbursement and Regulatory Risks: AdaptHealth relies heavily on reimbursements from Medicare, Medicaid, and commercial insurance payors, with approximately 25% of its revenue coming from Medicare/Medicaid. This exposes the company to substantial risks from potential Centers for Medicare & Medicaid Services (CMS) rate cuts, competitive bidding programs that have historically reduced durable medical equipment (DME) payments, and stricter prior authorization rules or coverage criteria from private insurers. Regulatory changes, audits, and state-level licensure adjustments could also impact volume or lead to penalties. Furthermore, AdaptHealth has faced allegations of False Claims Act violations related to improper billing for respiratory devices, resulting in settlements.

2. High Debt Levels and Rising Interest Costs: The company operates with a significant amount of debt, estimated at around $2 billion, much of which is variable-rate. This high leverage, reflected in a net-debt-to-EBITDA ratio of approximately 3.3x, makes AdaptHealth vulnerable to rising interest rates, as each 100 basis point increase can add roughly $20 million to annual interest expense. A weak interest cover further highlights the financial burden and could limit the company's flexibility and financial health.

3. Supply Chain Vulnerabilities, Inflation, and Labor Shortages: AdaptHealth's dependence on a limited number of suppliers for a majority of its patient service equipment and supplies creates inherent supply chain risks. Beyond this, the company faces ongoing challenges from broader inflationary pressures, including rising vendor prices, fuel costs for its delivery fleet, and wage inflation, which can negatively impact revenue and EBITDA margins. Labor shortages also present operational hurdles in the highly competitive healthcare-at-home industry.

• Shift of Diabetes-related Supplies to Pharmacy Benefit: Many continuous glucose monitors (CGMs) and insulin pump supplies, historically covered under the Durable Medical Equipment (DME) benefit and provided by companies like AdaptHealth, are increasingly moving to be covered under the pharmacy benefit. This trend allows patients to obtain these critical supplies directly from retail or mail-order pharmacies, effectively bypassing traditional HME providers and directly impacting AdaptHealth's diabetes segment by altering the distribution channel.
• Emergence and Adoption of Non-CPAP Alternatives for Sleep Apnea: While CPAP remains the primary treatment for obstructive sleep apnea (OSA), alternative therapies are gaining significant traction. A prominent example is implantable neurostimulation devices (e.g., Inspire Medical's system), which offer a non-CPAP solution for moderate to severe OSA. As these alternatives gain greater patient acceptance and reimbursement coverage, they represent a clear competitor to AdaptHealth's core sleep therapy equipment and supply business.
• Growth of Direct-to-Consumer (DTC) and Telehealth Models for Sleep Therapy: New digital health platforms and telehealth providers are emerging that offer a streamlined, direct-to-consumer pathway for sleep apnea diagnosis, prescription, and fulfillment of CPAP equipment and supplies. These models leverage online sleep studies, virtual consultations, and direct delivery, potentially bypassing the traditional referral networks and in-person HME provider interactions that AdaptHealth relies on, thereby disrupting the established service delivery model.

AdaptHealth Corp. (AHCO) operates within several significant addressable markets in the United States for its home medical equipment and related services.

• Sleep Therapy Equipment, Supplies, and Related Services (CPAP and Bi-PAP): The U.S. sleep apnea devices market was valued at approximately USD 2.90 billion in 2025 and is projected to reach USD 4.54 billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 7.8% from 2025 to 2031. The U.S. Continuous Positive Airway Pressure (CPAP) Devices Market alone was valued at USD 632.10 million in 2024 and is projected to reach USD 820.85 million by 2030.

• Medical Devices and Supplies for Diabetes (Continuous Glucose Monitors and Insulin Pumps): The U.S. diabetes care devices market was estimated at USD 21.4 billion in 2025 and is expected to grow to USD 61.4 billion by 2034, with a CAGR of 12.4% during the forecast period from 2025 to 2034.

• Home Medical Equipment (HME): The broader U.S. home medical equipment market size was estimated at USD 44.25 billion in 2025 and is projected to reach approximately USD 180.74 billion by 2035, growing at a CAGR of 15.11% from 2026 to 2035.

• Oxygen and Related Chronic Therapy Services in the Home: The U.S. oxygen therapy market's size is approximately USD 7.2 billion in 2025. More specifically, the U.S. oxygen therapy-device market is projected to reach a valuation of USD 4 billion by 2028.

• Other HME Devices and Supplies (Wound Care, Urological, Incontinence, Ostomy, and Nutritional Supply Needs):

  • Wound Care: The U.S. wound care market was valued at USD 7.5 billion in 2025 and is projected to grow to USD 12.5 billion by 2035, expanding at a CAGR of 5.4% from 2026 to 2035.
  • Incontinence and Ostomy Care Products: The United States incontinence and ostomy care products market was valued at USD 5,850.2 million in 2024 and is projected to reach USD 10,121.2 million by 2035, growing at a CAGR of 5.11% from 2025 to 2035.
  • Specific addressable market sizes for "urological supplies" (separate from incontinence) and "nutritional supply needs" were not distinctly identified and are likely integrated into broader HME market categories.

• Ramp-up of New Capitated Contracts: AdaptHealth has secured a significant new capitated agreement, including a major contract with a national hospital, which is anticipated to generate at least $200 million in annual revenue starting in 2026. This contract, along with others, is projected to contribute 5% to 6% of the company's 2026 revenue growth.
• Strategic Mergers and Acquisitions (M&A): The company plans to resume modest M&A activity in 2026, aiming to expand its geographic footprint and increase market share. Historically, AdaptHealth has pursued inorganic growth, having acquired numerous companies since 2012.
• Organic Growth in Sleep and Respiratory Health Segments: AdaptHealth anticipates continued strong performance in its sleep and respiratory health businesses. The sleep business saw a rebound with 128,000 new patient starts in Q2 2025, and both sleep and respiratory health segments have achieved record patient census. These segments are projected to outpace the diabetes health segment in growth.
• Diabetes Business Turnaround: After facing some challenges, AdaptHealth's diabetes business is projected to return to growth in the second half of 2025 and continue expanding into 2026. The company has made operational improvements, leading to record retention rates in diabetes health and a doubling of pharmacy revenue in this segment over the past six quarters.
• Investments in Technology and Operational Efficiency: AdaptHealth is leveraging technology such as the MyAdapt app and AgenTik AI to enhance patient engagement, streamline operations, and improve efficiency. These investments have reduced setup times and are expected to contribute to better service delivery and overall growth.

Capital Allocation Decisions of AdaptHealth (AHCO)

Share Repurchases

• AdaptHealth did not report any share repurchases in 2025 or for 2026 as of February 2026.

Share Issuance

• In January 2021, AdaptHealth completed a public offering of 7,250,000 shares of its Class A Common Stock at $33.00 per share, generating gross proceeds of approximately $239.25 million.
• The proceeds from the January 2021 offering were intended to finance approximately half of the previously announced acquisition of AeroCare Holdings, Inc., with the remainder for general corporate purposes, including future acquisitions, capital expenditures, and working capital.

Inbound Investments

• In March 2026, Richard M. Cashin Jr., a ten percent owner of AdaptHealth, acquired 2,046,691 shares of the company's common stock for approximately $19.9 million in open-market purchases.

Outbound Investments

• AdaptHealth completed the acquisition of AeroCare Holdings, Inc. on February 1, 2021, for a total purchase price of approximately $2 billion, which included $1.1 billion in cash and 31 million shares of AdaptHealth.
• In 2025, AdaptHealth deployed a little over $40 million towards tuck-in acquisitions, with a similar plan indicated for 2026.
• In late 2025 and early 2026, the company acquired certain assets of a home medical equipment provider for $47.6 million to support a new capitated contract, and also acquired a Hawaii-based HME provider.

Capital Expenditures

• AdaptHealth made significant investments in critical infrastructure and nearly 500 dedicated employees in 2025 to secure the initial start dates of a new key capitated agreement.
• The company views 2025 as a "transition and investment" year, focusing on operational streamlining and infrastructure buildout, including investments in employees, vehicles, locations, and equipment to support a major new exclusive capitated durable medical equipment (DME) agreement with Kaiser Permanente.
• In late February 2026, AdaptHealth invested $47.60 million in recently acquired home medical equipment assets.